Pancreatic β-cell mass in European subjects with type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 10, Issue SUPPL. 4, 2008, Pages 32-42

  Rahier, Jacques ^a,b   Guiot, Y ^a   Goebbels, R M ^a   Sempoux, C ^a   Henquin, J C ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Insulin content; Insulin secretion; Morphometry; Pancreatic islet; Pathophysiology; Type 2 diabetes; cell dysfunction; cell mass

Indexed keywords

INSULIN;

ADULT; AGED; AGING; BODY MASS; CELL DENSITY; CELL VOLUME; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE HOMEOSTASIS; HORMONE DETERMINATION; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN WEIGHT; PANCREAS ISLET BETA CELL; PANCREAS ISLET BETA CELL MASS; PANCREAS ISLET CELL FUNCTION; PANCREAS WEIGHT; SEX DIFFERENCE;

EID: 53549093011     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00969.x     Document Type: Conference Paper

References (51)

1. Maclean N, Ogilvie RF. Observations on the pancreatic islet tissue of young diabetic subjects. Diabetes 1959; 8: 83-91.
2. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619-639.
3. Doniach I, Morgan AG. Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol 1973; 2: 233-248.
4. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983; 24: 366-371.
5. Cerasi E. Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: Is divorce possible? Diabetologia 1995; 38: 992-997.
6. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19.
7. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis. J Clin Endocrinol Metab 2005; 90: 493-500.
8. Cohen A, Horton ES. Progress in the treatment of type 2 diabetes: New pharmacologic approaches to improve glycemic control. Curr Med Res Opin 2007; 23: 905-917.
9. Pfeifer MA, Halter JB, Porte D. Insulin secretion in diabetes mellitus. Am J Med 1981; 70: 579-588.
10. Matthews DR, Lang DA, Burnett MA, Turner RC. Control of pulsatile insulin secretion in man. Diabetologia 1983; 24: 231-237.
11. Polonsky KS. The β-cell in diabetes: From molecular genetics to clinical research. Diabetes 1995; 44: 705-717.
12. Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 1997; 46: 1725-1732.
13. Sempoux C, Guiot Y, Dubois D, Moulin P, Rahier J. Human type 2 diabetes: morphological evidence for abnormal β-cell function. Diabetes 2001; 50 (Suppl. 1): S172-S177.
14. Fernandez-Alvarez J, Conget I, Rasschaert J, Sener A, Gomis R, Malaisse WJ. Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1994; 37: 177-181.
15. Marchetti P, Del Guerra S, Marselli L et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004; 89: 5535-5541.
16. Deng S, Vatamaniuk M, Huang X et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004; 53: 624-632.
17. Maclean N, Ogilvie RF. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 1955; 4: 367-376.
18. Gepts W. Die histopathologischen Veränderungen der Langerhansschen Inseln und ihre Bedeutung in der Frage der Pathogenese des menschlichen Diabetes. Endokrinologie 1958; 36: 185-211.
19. Vishwanathan KA, Bazaz-Malik G, Dandekar J, Vaishnava H. A qualitative and quantitative histological study of the islets of Langerhans in diabetes mellitus. Ind J Med Sci 1972; 26: 807-812.
20. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 1978; 15: 417-421.
21. Saito K, Takahashi T, Yaginuma N, Iwama N. Islet morphometry in the diabetic pancreas of man. Tohoku J Exp Med 1978; 125: 185-197.
22. Saito K, Yaginuma N, Takahashi T. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 1979; 129: 273-283.
23. Clark A, Jones LC, de Koning E, Hansen BC, Matthews DR. Decreased insulin secretion in type 2 diabetes: A problem of cellular mass or function? Diabetes 2001; 50 (Suppl. 1): S169-S171.
24. Clark A, Wells CA, Buley ID et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in pancreas in type 2 diabetes. Diabetes Res 1988; 9: 151-159.
25. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 2002; 45: 85-96. 85-96.
26. Yoon KH, Ko SH, Cho JH et al. Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocr Metab 2003; 88: 2300-2308.
27. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 1982; 31: 694-700.
28. Klöppel G, Lohr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes revisited. Surv Synth Pathol Res 1985; 4: 110-125.
29. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
30. Sempoux C, Guiot Y, Lefevre A et al. Neonatal hyperinsulinemic hypoglycaemia: Heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 1998; 83: 1455-1461.
31. Chalkley HW. Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 1943; 4: 47-53.
32. Weibel ER. Stereological techniques for electron microscopic morphometry. In: Hayat MA ed. Principles and Techniques of Electron Microscopy. New York, NY: Van Nostrand Reinhold, 1973; 239-296.
33. Scott DA, Fischer AM. The insulin and zinc content of normal and diabetic pancreas. J Clin Invest 1938; 17: 727-731.
34. Hellman B. The frequency distribution of the number and volume of the islets Langerhans in man. I. Studies on non-diabetic adults. Acta Soc Med Ups 1959; 64: 432-460.
35. Wittingen J, Frey CF. Islet concentration in the head, body, tail and uncinate process of the pancreas. Ann Surg 1974; 179: 412-414.
36. Ferrannini E, Camastra S, Gastaldelli A et al. β-Cell function in obesity: Effects of weight loss. Diabetes 2004; 53 (Suppl. 3): S26-S33.
37. Remacle C, Dumortier O, Bol V et al. Intrauterine programming of the endocrine pancreas. Diabetes Obes Metab 2007; 9 (Suppl. 2): 196-209.
38. Wrenshall GA, Bogoch A, Ritchie RC. Extractable insulin of pancreas. Correlation with pathological and clinical findings in diabetic and nondiabetic cases. Diabetes 1952; 1: 87-107.
39. Steinke J, Soeldner JS, Renold AE. Measurement of small quantities of insulin-like activity with rat adipose tissue. IV Serum insulin-like activity and tumor insulin content in patients with functioning islet-cell tumors. J Clin Invest 1963; 42: 1322-1329.
40. Kimmel JR, Pollock HG. Studies of human insulin from nondiabetic and diabetic pancreas. Diabetes 1967; 16: 687-694.
41. Rastogi GK, Sinha MK, Dash RJ. Insulin and proinsulin content of pancreases from diabetic and nondiabetic subjects. Diabetes 1973; 22: 804-807.
42. Tasaka Y, Marumo K, Inoue Y, Hirata Y. C-peptide immunoreactivity and insulin content in the diabetic human pancreas and the relation to the stability of diabetic serum glucose level. Acta Endocrinol 1986; 113: 355-362.
43. Gepts W, Gregoire F, Van Assche A, deGasparo M. Quantitative enzyme pattern and insulin content of human islets of Langerhans. In: Falkmer S, Hellman B, Taljedal IB eds. The Structure and Metabolism of the Pancreatic Islets. Oxford: Pergamon Press, 1970; 283-303.
44. Slezak LA, Andersen DK. Pancreatic resection: Effects on glucose metabolism. World J Surg 2001; 25: 452-460.
45. Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 1990; 322: 898-903.
46. Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 1992; 89: 1761-1766.
47. Robertson RP, Lanz KJ, Sutherland DER, Seaquist ER. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002; 73: 736-741.
48. Kumar AF, Gruessner RWG, Seaquist ER. Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 2008; 31: 1639-1643.
49. Peshavaria M, Larmie BL, Lausier J et al. Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% pancreatectomized mouse. Diabetes 2006; 55: 3289-3298.
50. Menge BA, Tannapfel A, Belyaev O et al. Partial pancreatectomy in adult humans does not provoke β-cell regeneration. Diabetes 2008; 57: 142-149.
51. UK Prospective Diabetes Study Group. Overview of 6 years'therapy of type 2 diabetes: A progressive disease. Diabetes 1995; 44: 1249-1258.